Biologics Comparability Assessment Training Course

Name: Biologics Comparability Assessment and Regulatory Strategy Training Course
Availability: InStock

Plan, evaluate, and document evidence that biological products remain comparable after manufacturing and lifecycle changes.

Biologics Comparability Assessment Training Course

At a glance

Duration: 1 Week
Format: Classroom
Cities: Nice, Sharm El-Sheikh, Abu Dhabi, Lisbon, Cape town, Milan and more
Next session: 9 – 13 November 2026, Nice
Average fee: 5,750 €

Home
Our Categories
Biologics Comparability Assessment and Regulatory Strategy Training Course

Download Brochure (PDF) Print PDF

Overview

Biologics Comparability Assessment and Regulatory Strategy Training Course is a one-week course for CMC, analytical, quality, manufacturing, and regulatory functions who leave with a Biologics Comparability Evidence File. Participants connect manufacturing change assessment, critical quality attributes, analytical comparability, functional characterization, stability evidence, and regulatory strategy through ICH Q5E principles. Agile Leaders Training Center presents biologics comparability assessment and regulatory strategy.

Who Should Attend

Functions responsible for CMC change assessment and lifecycle submissions
Teams responsible for analytical development, characterization, and method suitability
Quality functions responsible for change control and product-quality evidence
Process and manufacturing functions responsible for site, scale, equipment, or formulation changes
Regulatory functions responsible for evidence strategy and authority interactions

The course assumes participants evaluate biological-product or manufacturing data at work and leaves biosimilar development, routine release testing, and laboratory method execution outside its scope.

Departments and Industries

The course supports departments and industries that govern biological products through manufacturing changes.

Biopharmaceutical CMC and regulatory affairs functions
Analytical development and product characterization teams
Quality assurance, change control, and technical operations
Biotechnology manufacturing and contract development organizations
Advanced-therapy, vaccine, and therapeutic-protein organizations

Learning Objectives

By the end of this course, participants will be able to:

Analyze manufacturing changes and product-knowledge risks
Prioritize critical quality attributes and evidence tiers
Evaluate structural, functional, impurity, and stability data
Apply statistical methods to pre-change and post-change comparisons
Build justified nonclinical and clinical bridging decisions
Develop a comparability protocol and regulatory evidence file

Course Agenda

Day 1: Frame the Comparability Exercise

ICH Q5E Comparability Principles Map
Manufacturing Change Impact Assessment Matrix
Product and Process Knowledge Evidence Map
Critical Quality Attribute Risk-Ranking Method
Pre-Change and Post-Change Lot Selection Plan

Day 2: Design the Analytical Evidence

Structural Characterization Evidence Matrix
Biological Function and Potency Assay Strategy
Product-Related Substance and Impurity Comparison Grid
Analytical Method Suitability Decision Tree
Stability and Degradation-Pathway Comparison Plan

Day 3: Evaluate Comparability Data

Quality Attribute Acceptance-Criteria Rationale
Tiered Statistical Comparison Method
Lot Variability and Reference-Range Analysis
Difference Signal and Clinical-Relevance Assessment
Residual Uncertainty and Evidence-Gap Register

Day 4: Build the Regulatory Strategy

Quality-to-Nonclinical Evidence Escalation Model
Clinical Bridging Decision Framework
Comparability Protocol Structure and Governance
Regulatory Interaction Question-and-Evidence Pack
Comparability Assessment Report Traceability Matrix

Day 5: Practice Comparability Decisions

Suggested Exercise: Classify a Manufacturing Change
Suggested Exercise: Rank Critical Quality Attributes
Suggested Exercise: Interpret an Analytical Difference
Suggested Exercise: Defend a Bridging Decision
Capstone Exercise: Present a Biologics Comparability Evidence File

Practical Exercises

The course uses suggested activities to turn manufacturing-change scenarios into traceable comparability decisions.

Suggested activity: map a site-transfer or scale change to affected process parameters and quality attributes.
Suggested activity: evaluate structural, functional, impurity, and stability results against a documented evidence strategy.
Suggested activity: decide whether residual uncertainty requires additional quality, nonclinical, or clinical evidence.
Suggested activity: assemble a protocol, report structure, and regulator-question response pack.

FAQs

Who suits biologics comparability assessment training, and what does it assume?

Biologics comparability assessment training suits professionals who already evaluate biological-product, process, analytical, quality, or regulatory evidence and need a structured method for manufacturing-change decisions.

How does biologics comparability assessment differ from biosimilar development training?

Biologics comparability assessment compares a manufacturer's product before and after a process change, while biosimilar development compares a proposed product with an external reference product.

When can analytical comparability support a manufacturing change?

Analytical comparability can support a change when structural, functional, impurity, stability, process, and method evidence adequately addresses the identified product-quality risks and residual uncertainty.

When does a biologics comparability exercise need bridging evidence?

Bridging evidence becomes relevant when quality data cannot resolve differences or their possible implications for safety and efficacy; the extent is justified case by case.

What belongs in a biologics comparability protocol?

A biologics comparability protocol states the change, risk rationale, attributes, lots, methods, acceptance approach, statistical plan, stability evidence, decision rules, governance, and reporting path.

Conclusion

Participants take a Biologics Comparability Evidence File back to their organization. It links change risk, quality attributes, analytical results, uncertainty, bridging decisions, and regulatory documentation. The file changes disconnected studies into a traceable assessment route with defined evidence, decision rules, responsibilities, and review points.

credits: 5 credit per day

Course Mode: full-time

Provider: Agile Leaders Training Center

Download Brochure (PDF) Print PDF

Showing 1-20 of 76 events

Location	Dates	Duration	Mode	Price
Nice	Week 46, 2026 9 – 13 November 2026	1 Week	Onsite	€5,700
Sharm El-Sheikh	Week 47, 2026 16 – 20 November 2026	1 Week	Onsite	€4,100
Abu Dhabi	Week 47, 2026 16 – 20 November 2026	1 Week	Onsite	€4,700
Lisbon	Week 48, 2026 23 – 27 November 2026	1 Week	Onsite	€5,700
Cape town	Week 48, 2026 29 November – 3 December 2026	1 Week	Onsite	€4,500
Milan	Week 49, 2026 30 November – 4 December 2026	1 Week	Onsite	€5,700
Tashkent	Week 49, 2026 6 – 10 December 2026	1 Week	Onsite	€4,500
London	Week 50, 2026 7 – 11 December 2026	1 Week	Onsite	€5,700
Lagos	Week 50, 2026 13 – 17 December 2026	1 Week	Onsite	€4,100
Doha	Week 51, 2026 20 – 24 December 2026	1 Week	Onsite	€5,500
Dubai	Week 53, 2026 28 December 2026 – 1 January 2027	1 Week	Onsite	€4,500
Singapore	Week 53, 2026 28 December 2026 – 1 January 2027	1 Week	Onsite	€5,700
Paris	Week 01, 2027 4 – 8 January 2027	1 Week	Onsite	€5,700
Geneva	Week 01, 2027 10 – 14 January 2027	1 Week	Onsite	€6,200
Johannesburg	Week 02, 2027 17 – 21 January 2027	1 Week	Onsite	€4,500
Kuala Lumpur	Week 03, 2027 18 – 22 January 2027	1 Week	Onsite	€5,200
Baku	Week 04, 2027 25 – 29 January 2027	1 Week	Onsite	€5,000
Athens	Week 04, 2027 25 – 29 January 2027	1 Week	Onsite	€6,700
Langkawi	Week 04, 2027 31 January – 4 February 2027	1 Week	Onsite	€6,000
Manama	Week 05, 2027 7 – 11 February 2027	1 Week	Onsite	€4,700

Frequently asked questions

What does this course cover?

OverviewBiologics Comparability Assessment and Regulatory Strategy Training Course is a one-week course for CMC, analytical, quality, manufacturing, and regulatory functions who leave with a Biologics Comparability Evidence File. Participants connect manufacturing change assessment, critical quality attributes, analytical comparability, functional charact…

Are training dates available?

Yes. Available dates and destinations are listed in the course dates section on this page.

How can I register?

Choose an available date on this page and complete the registration form, or send a programme enquiry.

Can I download the course brochure?

Yes. Use the brochure download link provided on this page.

Biologics Comparability Assessment Training Course